| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9312 |
| Human Intestinal Absorption | HIA- | 0.6825 |
| Caco-2 Permeability | Caco2- | 0.6544 |
| P-glycoprotein Substrate | Non-substrate | 0.8777 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9450 |
| Non-inhibitor | 0.9870 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9581 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5495 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8713 |
| CYP450 2D6 Substrate | Non-substrate | 0.8206 |
| CYP450 3A4 Substrate | Non-substrate | 0.7189 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8299 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7930 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9154 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8183 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9865 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9784 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8522 |
| Non-inhibitor | 0.9262 |
| AMES Toxicity | Non AMES toxic | 0.7718 |
| Carcinogens | Carcinogens | 0.8220 |
| Fish Toxicity | Low FHMT | 0.7382 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8466 |
| Honey Bee Toxicity | High HBT | 0.7245 |
| Biodegradation | Ready biodegradable | 0.8064 |
| Acute Oral Toxicity | III | 0.6693 |
| Carcinogenicity (Three-class) | Non-required | 0.6904 |